mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.03 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.41 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
XMD8-92 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.04 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |